Scar
Conditions
Interventions
High-dose group:Immediately after the operation, it was divided into two parts with the midpoint of the suture mouth as the boundary, and the side of the high-dose injection (8U/point) was determined
Low-dose group:Immediately after the operation, it was divided into two parts with the midpoint of the suture mouth as the boundary, and the side of the low-dose injection (4U/point) was determined ac
Sponsors
The First Affiliated Hospital of Zhengzhou University
Eligibility
Sex/Gender
All
Age
16 Years to 60 Years
Inclusion criteria
Inclusion criteria: 1. The type of incision is a type I surgical incision, and all have plastic and cosmetic sutures. The length of the postoperative scar on the body surface is > 3cm; 2. Aged 16-60 years; 3. No other adjuvant treatments such as radiotherapy or pressure therapy have been received at the surgical incision; 4. Have not received various forms of BTxA treatment in the past; 5. Sign informed consent.
Exclusion criteria
Exclusion criteria: 1. Patients with a history of chronic system diseases such as diabetes and cardiovascular disease; 2. Patients with scar constitution; 3. Patients with malignant tumors; 4. Serious systemic diseases; 5. Pregnant or lactating women; 6. Those who cannot tolerate surgery; 7. Other patients with contraindications to botulinum toxin type A for injection; 8. Other situations deemed inappropriate for selection.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| the modified Stony Brook Scar Evaluation Scale;the Visual Analogue Scale; | — |
Countries
China
Contacts
Public ContactGuangshuai Li
Department of Plastic and Reconstructive Surgery ,The First Affiliated Hospital of Zhengzhou University
Outcome results
None listed